Table 2.
Frequency of CCND1 amplification in melanoma cell lines and melanoma tumor samples
Total number of samples | 47 Melanoma cell lines (%) | 67 Melanoma tumor samples (%) |
---|---|---|
Total CGH CCND1 amplifications | 12/47 (25) | 11/67 (17) |
CCND1 amplifications, BRAF group | 9/36 (25) | 7/29 (24) |
CCND1 amplifications, NRAS group | 1/8 (12.5) | 2/18 (11) |
CCND1 amplifications, BRAF/NRAS wild-type | 2/3 (67) | 2/20 (10) |